GPT and metabolic dysfunction-associated steatohepatitis: Gly-MCA was orally administered every day for 8 weeks (10 mg/ kg of body weight). Reduced lipid accumulation, inflammatory response (in injury markers, ALT and AST), and collagen deposition in NAFLD and NASH models. Lower liver endoplasmic reticulum stress and proinflammatory cytokine production (97).